Benedict Financial Advisors Inc Amgen Inc Transaction History

Benedict Financial Advisors Inc

  • $421 Million
  • Q3 2024

A detailed history of Benedict Financial Advisors Inc transactions in Amgen Inc stock. As of the latest transaction made, Benedict Financial Advisors Inc holds 32,278 shares of AMGN stock, worth $8.5 Million. This represents 2.47% of its overall portfolio holdings.

Number of Shares
32,278
Previous 32,445 0.51%
Holding current value
$8.5 Million
Previous $10.1 Million 2.59%
% of portfolio
2.47%
Previous 2.59%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024
SELL
$309.38 - $337.38 $51,666 - $56,342
-167 Reduced 0.51%
32,278 $10.4 Million
Q2 2024

Jul 30, 2024
SELL
$262.75 - $319.31 $110,617 - $134,429
-421 Reduced 1.28%
32,445 $10.1 Million
Q1 2024

Apr 25, 2024
SELL
$268.87 - $324.56 $39,792 - $48,034
-148 Reduced 0.45%
32,866 $9.34 Million
Q4 2023

Jan 29, 2024
BUY
$255.7 - $288.46 $49,094 - $55,384
192 Added 0.58%
33,014 $9.51 Million
Q3 2023

Oct 18, 2023
BUY
$218.65 - $271.46 $55,755 - $69,222
255 Added 0.78%
32,822 $8.82 Million
Q2 2023

Aug 10, 2023
BUY
$214.27 - $253.37 $130,490 - $154,302
609 Added 1.91%
32,567 $7.23 Million
Q1 2023

May 11, 2023
BUY
$225.79 - $275.2 $111,766 - $136,224
495 Added 1.57%
31,958 $7.73 Million
Q4 2022

Feb 14, 2023
SELL
$229.03 - $291.01 $71,686 - $91,086
-313 Reduced 0.99%
31,463 $8.26 Million
Q3 2022

Nov 07, 2022
BUY
$224.46 - $253.15 $27,833 - $31,390
124 Added 0.39%
31,776 $7.16 Million
Q2 2022

Jul 28, 2022
BUY
$230.71 - $256.74 $126,890 - $141,207
550 Added 1.77%
31,652 $7.7 Million
Q1 2022

May 03, 2022
BUY
$219.27 - $242.57 $141,867 - $156,942
647 Added 2.12%
31,102 $7.52 Million
Q4 2021

Feb 09, 2022
BUY
$198.88 - $227.6 $184,162 - $210,757
926 Added 3.14%
30,455 $6.85 Million
Q3 2021

Oct 29, 2021
BUY
$212.27 - $248.7 $171,301 - $200,700
807 Added 2.81%
29,529 $6.28 Million
Q2 2021

Aug 05, 2021
BUY
$233.58 - $259.14 $118,425 - $131,383
507 Added 1.8%
28,722 $7 Million
Q1 2021

May 10, 2021
BUY
$221.91 - $258.6 $74,117 - $86,372
334 Added 1.2%
28,215 $7.02 Million
Q4 2020

Feb 02, 2021
BUY
$216.38 - $257.67 $107,540 - $128,061
497 Added 1.81%
27,881 $6.41 Million
Q3 2020

Nov 03, 2020
BUY
$234.65 - $260.95 $122,487 - $136,215
522 Added 1.94%
27,384 $6.96 Million
Q2 2020

Jul 23, 2020
BUY
$197.81 - $242.74 $12,659 - $15,535
64 Added 0.24%
26,862 $6.34 Million
Q1 2020

Apr 21, 2020
BUY
$182.24 - $241.7 $39,181 - $51,965
215 Added 0.81%
26,798 $5.43 Million
Q4 2019

Feb 04, 2020
BUY
$189.21 - $243.2 $47,113 - $60,556
249 Added 0.95%
26,583 $6.41 Million
Q3 2019

Nov 04, 2019
BUY
$174.11 - $208.62 $55,541 - $66,549
319 Added 1.23%
26,334 $5.1 Million
Q2 2019

Aug 01, 2019
BUY
$166.7 - $195.41 $142,861 - $167,466
857 Added 3.41%
26,015 $4.79 Million
Q1 2019

May 01, 2019
BUY
$180.87 - $203.88 $112,320 - $126,609
621 Added 2.53%
25,158 $4.78 Million
Q4 2018

Jan 30, 2019
BUY
$178.4 - $208.25 $48,881 - $57,060
274 Added 1.13%
24,537 $4.78 Million
Q3 2018

Nov 05, 2018
BUY
$185.29 - $208.89 $48,545 - $54,729
262 Added 1.09%
24,263 $5.03 Million
Q2 2018

Jul 24, 2018
BUY
$166.05 - $186.51 $95,146 - $106,870
573 Added 2.45%
24,001 $4.43 Million
Q1 2018

May 02, 2018
BUY
$169.43 - $198.0 $35,749 - $41,778
211 Added 0.91%
23,428 $3.99 Million
Q4 2017

Feb 05, 2018
BUY
$168.79 - $188.59 $60,258 - $67,326
357 Added 1.56%
23,217 $4.04 Million
Q3 2017

Oct 26, 2017
BUY
$167.29 - $191.0 $3.82 Million - $4.37 Million
22,860
22,860 $4.26 Million

Others Institutions Holding AMGN

# of Institutions
3,125
Shares Held
409M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Benedict Financial Advisors Inc Portfolio

Follow Benedict Financial Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benedict Financial Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Benedict Financial Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email